(Q33383964)

26 July 2017

title

Dose-finding study of 153Sm-EDTMP in patients with poor-prognosis osteosarcoma (English)

1 reference

samarium (153sm) lexidronam

26 July 2017

main subject

1 reference

5

George Sgouros

1 reference

26 July 2017

3

Robert F Hobbs

1 reference

26 July 2017

7

Moody D Wharam

1 reference

26 July 2017

1

David M Loeb

1 reference

26 July 2017

6

Ori Shokek

1 reference

26 July 2017

8

Tammy Scott

1 reference

26 July 2017

9

Cindy L Schwartz

1 reference

26 July 2017

author name string

Elizabeth Garrett-Mayer

series ordinal

2

1 reference

26 July 2017

Andrew R Prideaux

series ordinal

4

1 reference

26 July 2017

language of work or name

English

0 references

publication date

1 June 2009

1 reference

26 July 2017

1 reference

26 July 2017

volume

115

1 reference

26 July 2017

issue

11

1 reference

26 July 2017

page(s)

2514-2522

1 reference

Samarium lexidronam (153Sm-EDTMP): skeletal radiation for osteoblastic bone metastases and osteosarcoma

26 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974628

High-dose samarium-153 ethylene diamine tetramethylene phosphonate: low toxicity of skeletal irradiation in patients with osteosarcoma and bone metastases

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974628

MIRD pamphlet no. 16: Techniques for quantitative radiopharmaceutical biodistribution data acquisition and analysis for use in human radiation dose estimates

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974628

Continual reassessment method: a practical design for phase 1 clinical trials in cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974628

Gemcitabine radiosensitization after high-dose samarium for osteoblastic osteosarcoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974628

Some practical improvements in the continual reassessment method for phase I studies.

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974628

The continual reassessment method for dose-finding studies: a tutorial

31 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=2974628

Neoadjuvant chemotherapy and local radiotherapy for high-grade osteosarcoma of the extremities

31 October 2018

1 reference

12 December 2020

Osteosarcoma.An assessment of management with particular reference to primary irradiation and selective delayed amputation

1 reference

12 December 2020

The effect of adjuvant chemotherapy on relapse-free survival in patients with osteosarcoma of the extremity

1 reference

12 December 2020

Massive preoperative irradiation in the treatment of osteogenic sarcoma in children; a preliminary report

1 reference

12 December 2020

OSTEOSARCOMA. A STUDY OF THE VALUE OF PREOPERATIVE MEGAVOLTAGE RADIOTHERAPY

1 reference

12 December 2020

OLINDA/EXM: the second-generation personal computer software for internal dose assessment in nuclear medicine

1 reference

12 December 2020

Identifiers

DOI

10.1002/CNCR.24286

1 reference

26 July 2017

1 reference

26 July 2017

1 reference